← All Soligenix, INC filings

Soligenix, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
SNGX
Soligenix, INC
Form 4: SOLIGENIX CMO Granted 10,000 Stock Options
Soligenix, Inc. CMO Richard Straube was granted 10,000 stock options with an exercise price of $1.63, vesting over time.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CSO Donini Acquires 100,000 Stock Options
Soligenix Chief Scientific Officer Oreola Donini acquired 100,000 stock options with an exercise price of $1.63, vesting over time.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CFO Granted 100,000 Stock Options
Soligenix, Inc. CFO Jonathan L. Guarino was granted 100,000 stock options with an exercise price of $1.63, vesting over time.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CEO Granted 200,000 Stock Options
Soligenix, Inc. CEO Christopher J. Schaber was granted 200,000 stock options with an exercise price of $1.63, vesting over time.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CEO Buys 15,132 Shares in Open Market
Soligenix, Inc.'s Chairman, CEO, and President, Christopher J. Schaber, acquired 15,132 shares of common stock at a weighted-average price of $1.3217.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Anthony Lapointe Receives Equity Compensation Through Stock Option Grant
Soligenix, Inc. Director Anthony Gregg Lapointe was granted 17,647 stock options with an exercise price of $1.70, vesting ratably over four quarters.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Jerome Zeldis Granted Stock Options
Soligenix, Inc. Director Jerome B. Zeldis was granted 17,647 stock options with an exercise price of $1.70, vesting over one year.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Robert J. Rubin Granted Stock Options
Soligenix, Inc. Director and 10% owner Robert J. Rubin was granted 17,647 stock options with an exercise price of $1.70, vesting ratably over the next year.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Diane Parks Granted Stock Options
Soligenix, Inc. Director Diane L. Parks was granted 17,647 stock options with an exercise price of $1.70, vesting quarterly over one year.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Diane L. Parks Acquires Stock Options
Director Diane L. Parks acquired 8,646 stock options in Soligenix, Inc. on December 12, 2024.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CSO Acquires 20,000 Stock Options
Soligenix's Chief Scientific Officer, Oreola Donini, acquired 20,000 stock options on December 12, 2024, at an exercise price of $3.31.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CFO Acquires 20,000 Shares Through Stock Option Grant
Soligenix's Chief Financial Officer, Jonathan L. Guarino, acquired 20,000 shares through a stock option grant on December 12, 2024.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Executive Acquires 12,000 Stock Options
Richard Straube, Senior Vice President and CMO of Soligenix, Inc., acquired 12,000 stock options on December 12, 2024.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix CEO Acquires 45,000 Stock Options
Soligenix CEO Christopher J. Schaber acquired 45,000 stock options on December 12, 2024, which vest over a three-year period.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Acquires Stock Options
Director Anthony Gregg Lapointe acquired 8,646 stock options in Soligenix, Inc. on December 12, 2024.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Acquires Stock Options
Soligenix director Jerome B. Zeldis acquired 8,646 stock options on December 12, 2024, which vest over the next year.
NASDAQ
SNGX
Soligenix, INC
Form 4: Soligenix Director Acquires Stock Options
Robert J. Rubin, a director at Soligenix, Inc., acquired 8,646 stock options on December 12, 2024.